Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.
Mezigdomide treatment of ex vivo generated exhausted T cells in multiple myeloma is linked to decreased exhaustion-marker expression and increased proinflammatory cytokine expression.